sodium fluoride has been researched along with Neoplasm Metastasis in 18 studies
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sodium fluoride (Na-F) PET/CT is an imaging technique which allows radiolabeled fluoride to help detect areas of bone turnover." | 6.52 | Role of sodium fluoride PET imaging for identification of bony metastases in prostate cancer patients. ( Hughes, CT; Nix, JW, 2015) |
| "In a national prospective registry, we previously studied the impact of (18)F-sodium fluoride PET (NaF PET) on the intended management of cancer patients with osseous metastases." | 5.20 | 18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry. ( Duan, F; Hanna, L; Hillner, BE; Quinn, B; Shields, AF; Siegel, BA, 2015) |
| "We compared the diagnostic accuracy of F-labeled sodium fluoride (F-NaF) PET-CT with 99m-technetium methylene diphosphonate (Tc-MDP) single photon emission computed tomography (SPECT) to detect bone metastases (BMs) in patients with preoperative lung cancer." | 3.83 | 18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer. ( Chen, Z; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X; Zong, Z, 2016) |
| "Patients with osteoblastic metastases from high risk osteosarcoma continue to have a poor prognosis after progression from standard-of-care multi-agent chemotherapy." | 3.01 | ( Anderson, P; Kairemo, K; Macapinlac, HA; Rao, A; Ravizzini, G; Roszik, J; Subbiah, V, 2021) |
| "In biochemical relapse of prostate cancer, 18 F-NaF PET/CT is useful in the detection of occult osseous metastases, whereas the yield of 18F-FDG PET/CT is relatively limited." | 2.77 | Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer. ( Conti, PS; Desai, B; Dorff, TB; Groshen, SG; Gross, ME; Jadvar, H; Ji, L; Pinski, JK; Quinn, DI, 2012) |
| "We reviewed the literature for prostate cancer PET tracers that are either being used for patient management or being evaluated in clinical research trials." | 2.58 | Prostate cancer PET tracers: essentials for the urologist. ( Fraum, TJ; Hope, TA; Ippolito, JE; Kim, EH; Ludwig, DR; Schroeder, P, 2018) |
| "Sodium fluoride (Na-F) PET/CT is an imaging technique which allows radiolabeled fluoride to help detect areas of bone turnover." | 2.52 | Role of sodium fluoride PET imaging for identification of bony metastases in prostate cancer patients. ( Hughes, CT; Nix, JW, 2015) |
| "Sodium fluoride PET (18F-NaF) has recently reemerged as a valuable method for detection of osseous metastasis, with recent work highlighting the potential of coadministered 18F-NaF and 18F-FDG PET/CT in a single combined imaging examination." | 1.42 | Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone. ( Gambhir, SS; Iagaru, A; Lutz, AM; Mittra, ES; Mosci, C; Sampath, SC; Willmann, JK, 2015) |
| "A 43-year-old woman with breast cancer underwent Tc-hydroxymethylene diphosphonate bone scintigraphy for preoperative workup." | 1.42 | 18F-NaF PET/CT Findings in Fibrous Dysplasia. ( Lee, H; Lee, KS; Lee, WW, 2015) |
| "Sodium fluoride (NaF) is a bone-seeking positron-emitting tracer with high sensitivity and specificity for detection of osseous lesions, particularly osteolytic lesions." | 1.38 | Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans. ( Colletti, PM; Sheth, S, 2012) |
| "As bone metastases might be present in lung cancer despite a normal bone scan, we examined various alternatives prospectively." | 1.32 | F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. ( Arslandemir, C; Buck, AK; Gabelmann, A; Glatting, G; Hetzel, J; Hetzel, M; Hombach, V; König, HH; Nüssle, K; Schirrmeister, H, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 13 (72.22) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kairemo, K | 2 |
| Roszik, J | 1 |
| Anderson, P | 1 |
| Ravizzini, G | 1 |
| Rao, A | 1 |
| Macapinlac, HA | 1 |
| Subbiah, V | 2 |
| Khaw, TH | 1 |
| Raynor, WY | 1 |
| Borja, AJ | 1 |
| Al-Zaghal, A | 1 |
| Jonnakuti, VS | 1 |
| Cheng, N | 1 |
| Houshmand, S | 1 |
| Werner, TJ | 1 |
| Alavi, A | 1 |
| Morland, D | 1 |
| Godard, F | 1 |
| Lalire, P | 1 |
| Eymard, JC | 1 |
| Papathanassiou, D | 1 |
| Usmani, S | 1 |
| Marafi, F | 1 |
| Rasheed, R | 1 |
| Al Maraghy, M | 1 |
| Al Kandari, F | 1 |
| Fraum, TJ | 1 |
| Ludwig, DR | 1 |
| Kim, EH | 1 |
| Schroeder, P | 1 |
| Hope, TA | 1 |
| Ippolito, JE | 1 |
| Wang, WL | 1 |
| Sampath, SC | 2 |
| Mosci, C | 2 |
| Lutz, AM | 1 |
| Willmann, JK | 1 |
| Mittra, ES | 1 |
| Gambhir, SS | 2 |
| Iagaru, A | 2 |
| Hillner, BE | 1 |
| Siegel, BA | 1 |
| Hanna, L | 1 |
| Duan, F | 1 |
| Quinn, B | 1 |
| Shields, AF | 1 |
| Hughes, CT | 1 |
| Nix, JW | 1 |
| Jackson, T | 1 |
| von Eyben, R | 1 |
| Mittra, E | 1 |
| Ganjoo, K | 1 |
| Biswal, S | 1 |
| Simoncic, U | 1 |
| Perlman, S | 1 |
| Liu, G | 1 |
| Jeraj, R | 1 |
| Lee, H | 1 |
| Lee, KS | 1 |
| Lee, WW | 1 |
| Rao, L | 1 |
| Zong, Z | 1 |
| Chen, Z | 1 |
| Wang, X | 1 |
| Shi, X | 1 |
| Yi, C | 1 |
| Zhang, X | 1 |
| Zhu, Y | 1 |
| Chen, Y | 1 |
| Huang, Z | 1 |
| Liu, L | 1 |
| Sheth, S | 1 |
| Colletti, PM | 1 |
| Jadvar, H | 1 |
| Desai, B | 1 |
| Ji, L | 1 |
| Conti, PS | 1 |
| Dorff, TB | 1 |
| Groshen, SG | 1 |
| Gross, ME | 1 |
| Pinski, JK | 1 |
| Quinn, DI | 1 |
| Hetzel, M | 1 |
| Arslandemir, C | 1 |
| König, HH | 1 |
| Buck, AK | 1 |
| Nüssle, K | 2 |
| Glatting, G | 1 |
| Gabelmann, A | 1 |
| Hetzel, J | 1 |
| Hombach, V | 1 |
| Schirrmeister, H | 2 |
| Guhlmann, CA | 1 |
| Elsner, K | 1 |
| Träger, H | 1 |
| Kotzerke, J | 1 |
| Reske, SN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The National Oncologic PET Registry[NCT00868582] | 333,000 participants (Anticipated) | Observational | 2006-05-31 | Active, not recruiting | |||
| The Effectiveness of Whole-body 18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer: A Comparison Study With 99mTc-MDP Bone Scintigraphy.[NCT00414934] | 100 participants (Anticipated) | Observational | 2006-10-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for sodium fluoride and Neoplasm Metastasis
| Article | Year |
|---|---|
Prostate cancer PET tracers: essentials for the urologist.
Topics: Antigens, Surface; Carbon Radioisotopes; Carboxylic Acids; Cyclobutanes; Fluorine Radioisotopes; Flu | 2018 |
Role of sodium fluoride PET imaging for identification of bony metastases in prostate cancer patients.
Topics: Bone Neoplasms; Early Detection of Cancer; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomo | 2015 |
[Positron emission tomography of the skeletal system using 18FNa: frequency, distribution and appearance of skeletal metastases].
Topics: Bone Neoplasms; Contrast Media; Humans; Neoplasm Metastasis; Sodium Fluoride; Tomography, Emission-C | 1999 |
3 trials available for sodium fluoride and Neoplasm Metastasis
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Bone Neoplasms; Female; Fluorine Radioisotopes; Humans; Lung Neoplasms; Neoplasm | 2021 |
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Databases, Factual; Female; Fluorodeoxygl | 2015 |
Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer.
Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tom | 2012 |
12 other studies available for sodium fluoride and Neoplasm Metastasis
| Article | Year |
|---|---|
Assessing the effects of body weight on subchondral bone formation with quantitative
Topics: Aged; Aged, 80 and over; Body Weight; Bone Neoplasms; Female; Fluorine Radioisotopes; Humans; Male; | 2020 |
Superiority of NaF PET/CT Over Chest CT in a Case of Osteosarcoma.
Topics: Bone Neoplasms; Fluorine Radioisotopes; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Positron Em | 2021 |
Targeted Therapy With Anaplastic Lymphoma Kinase Inhibitor (Alectinib) in Adolescent Metastatic Non-Small Cell Lung Carcinoma: 18F-NaF PET/CT in Response Evaluation.
Topics: Adolescent; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carbazoles; Carcinoma, Non-Small-Cell | 2018 |
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology.
Topics: Adult; Bone Neoplasms; Cell Transformation, Neoplastic; Diagnosis, Differential; Female; Fluorodeoxy | 2019 |
Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle | 2015 |
Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm | 2015 |
Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neop | 2015 |
18F-NaF PET/CT Findings in Fibrous Dysplasia.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fibrous Dysplasia of Bone; Fluorine Radioi | 2015 |
18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplas | 2016 |
Unsuspected Metastatic Ovarian Cancer Revealed by 18F-NaF PET/CT Performed to Evaluate Lower-Back Pain.
Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Low Back | 2017 |
Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans.
Topics: Aged; Bone and Bones; Female; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Os | 2012 |
F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cost-Benefit Analysis; Decision Trees; Female; Fluor | 2003 |